The effect of niacin on facial blood flow in people with an elevated fear of negative evaluation

European Neuropsychopharmacology

Volumn 22, Issue 3, 2012, Pages 200-204

  Drummond, Peter D ^a   Lazaroo, Daniel ^a  

^a MURDOCH UNIVERSITY   (Australia)

Author keywords

Facial blood flow; Fear of negative evaluation; Niacin; Social anxiety; Vasodilatation

Indexed keywords

NICOTINIC ACID; PLACEBO;

ADULT; ANXIETY; ARTICLE; BLOOD FLOW; CLINICAL ARTICLE; CONTROLLED STUDY; DOUBLE BLIND PROCEDURE; FEAR; FEMALE; FLUSHING; HEAT; HUMAN; MALE; NONVERBAL COMMUNICATION; PRIORITY JOURNAL; PULSE RATE; SOCIAL PHOBIA;

ADOLESCENT; ADULT; ANXIETY; BLUSHING; FACE; FEAR; FEMALE; HUMANS; MALE; NIACIN; REGIONAL BLOOD FLOW; VASODILATION; VASODILATOR AGENTS;

EID: 84856544428     PISSN: 0924977X     EISSN: 18737862     Source Type: Journal    
DOI: 10.1016/j.euroneuro.2011.07.013     Document Type: Article

References (25)

1. Beidel D.C., Turner S.M., Dancu C.V. Physiological, cognitive and behavioral aspects of social anxiety. Behav. Res. Ther. 1985, 23:109-117.
2. Benyo Z., Gille A., Bennett C.L., Clausen B.E., Offermanns S. Nicotinic acid-induced flushing is mediated by activation of epidermal langerhans cells. Mol. Pharmacol. 2006, 70:1844-1849.
3. Bogels S.M., Alberts M., de Jong P.J. Self-consciousness, self-focused attention, blushing propensity and fear of blushing. Personal. Individ. Differ. 1996, 21:573-581.
4. Bogels S.M., Mansell W. Attention processes in the maintenance and treatment of social phobia: hypervigilance, avoidance and self-focused attention. Clin. Psychol. Rev. 2004, 24:827-856.
5. Bouwer C., Stein D.J. Hyperresponsivity to nicotinic acid challenge in generalized social phobia: a pilot study. Eur. Neuropsychopharmacol. 1998, 8:311-313.
6. Clark D.B., Feske U., Masia C.L., Spaulding S.A., Brown C., Mammen O., Shear M.K. Systematic assessment of social phobia in clinical practice. Depress. Anxiety 1997, 6:47-61.
7. Dijk C., Voncken M.J., de Jong P.J. I blush, therefore I will be judged negatively: influence of false blush feedback on anticipated others' judgments and facial coloration in high and low blushing-fearfuls. Behav. Res. Ther. 2009, 47:541-547.
8. Drummond P.D., Back K., Harrison J., Helgadottir F.D., Lange B., Lee C., Leavy K., Novatscou C., Orner A., Pham H., Prance J., Radford D., Wheatley L. Blushing during social interactions in people with a fear of blushing. Behav. Res. Ther. 2007, 45:1601-1608.
9. Glen A.I., Cooper S.J., Rybakowski J., Vaddadi K., Brayshaw N., Horrobin D.F. Membrane fatty acids, niacin flushing and clinical parameters. Prostaglandins Leukot. Essent. Fatty Acids 1996, 55:9-15.
10. Hudson C.J., Lin A., Cogan S., Cashman F., Warsh J.J. The niacin challenge test: clinical manifestation of altered transmembrane signal transduction in schizophrenia?. Biol. Psychiatry 1997, 41:507-513.
11. Katzman M., Cornacchi S., Coonerty-Femiano A., Hughes B., Vermani M., Struzik L., Ross B.M. Methyl nicotinate-induced vasodilation in generalized social phobia. Neuropsychopharmacology 2003, 28:1846-1851.
12. Leary M.R., Meadows S. Predictors, elicitors, and concomitants of social blushing. J. Personal. Soc. Psychol. 1991, 60:254-262.
13. Liu C.M., Chang S.S., Liao S.C., Hwang T.J., Shieh M.H., Liu S.K., Chen W.J., Hwu H.G. Absent response to niacin skin patch is specific to schizophrenia and independent of smoking. Psychiatry Res. 2007, 152:181-187.
14. Maclean R., Ward P.E., Glen I., Roberts S.J., Ross B.M. On the relationship between methylnicotinate-induced skin flush and fatty acids levels in acute psychosis. Prog. Neuropsychopharmacol. Biol. Psychiatry 2003, 27:927-933.
15. Mattick R.P., Clarke J.C. Development and validation of measures of social phobia scrutiny fear and social interaction anxiety. Behav. Res. Ther. 1998, 36:455-470.
16. Messamore E. Relationship between the niacin skin flush response and essential fatty acids in schizophrenia. Prostaglandins Leukot. Essent. Fatty Acids 2003, 69:413-419.
17. Messamore E., Hoffman W.F., Yao J.K. Niacin sensitivity and the arachidonic acid pathway in schizophrenia. Schizophr. Res. 2010, 122:248-256.
18. Mulkens S., de Jong P.J., Dobbelaar A., Bogels S.M. Fear of blushing: fearful preoccupation irrespective of facial coloration. Behav. Res. Ther. 1999, 37:1119-1128.
19. Nilsson B.M., Hultman C.M., Ekselius L. Test-retest stability of the oral niacin test and electrodermal activity in patients with schizophrenia. Prostaglandins Leukot. Essent. Fatty Acids 2009, 81:367-372.
20. Schweikart J., Reimann J., Schon C. Investigation of niacin on parameters of metabolism in a physiologic dose: randomized, double-blind clinical trial with three different dosages. Int. J. Food Sci. Nutr. 2009, 60(Suppl 5):192-202.
21. Smesny S., Rosburg T., Klemm S., Riemann S., Baur K., Rudolph N., Grunwald S., Sauer H. The influence of age and gender on niacin skin test results - implications for the use as a biochemical marker in schizophrenia. J. Psychiatr. Res. 2004, 38:537-543.
22. Voncken M.J., Bogels S.M. Physiological blushing in social anxiety disorder patients with and without blushing complaints: two subtypes?. Biol. Psychol. 2009, 81:86-94.
23. Watson D., Friend R. Measurement of social-evaluative anxiety. J. Consult. Clin. Psychol. 1969, 33:448-457.
24. Wilkin J.K., Wilkin O., Kapp R., Donachie R., Chernosky M.E., Buckner J. Aspirin blocks nicotinic acid-induced flushing. Clin. Pharmacol. Ther. 1982, 31:478-482.
25. Woody S.R., Rodriguez B.F. Self-focused attention and social anxiety in social phobics and normal controls. Cogn. Ther. Res. 2000, 24:473-488.